Piramal Enterprises (formerly Piramal Healthcare) has acquired the over-the-counter (OTC) brand CALADRYL in India from Valeant Pharmaceuticals International, Inc. The brand CALADRYL in India was owned by Valeant Pharmaceuticals International, Inc (Valeant). The rights to this brand were acquired by Valeant from Johnson & Johnson in the year 2012. CALADRYL is an anti-pruritic solution known for dermatosis application for minor skin irritations and itching.
This acquisition enables the company to widen its consumer products portfolio in the skin care segment. Piramal Enterprises’ current consumer products portfolio includes brands such as Lacto Calamine, Saridon, i-Pill, Itchmosol and Supractiv Complete, along with niche market brands like Polycrol, i-Sure, i-Can, Jungle Magic, Tetmosol and Triactiv. The division has one of India’s largest field forces in the industry covering more than 100,000 towns.
Piramal Enterprises is one of India’s largest diversified companies, with a presence in pharmaceutical, financial services and information management sectors.
